PARKINSON'S DISEASE (PD)

This study follows 250 adults with advanced Parkinson's disease who are prescribed ABBV-951 by their doctors. The goal is to see how safe and effective the drug is in everyday use over 52 weeks. Participants continue their normal care with no extra visits required.

This study tests a new way to use deep brain stimulation (DBS) for Parkinson's disease. Instead of constant stimulation, the device automatically switches settings when the person starts walking, aiming to improve gait and balance. Six people who already have a special DBS implan…

This study follows about 427 adults with advanced Parkinson's disease who are receiving ABBV-951, a continuous infusion under the skin. Researchers want to see how well it controls symptoms like tremors and stiffness over three years in everyday medical practice. Participants att…

This phase 2a trial tests whether the drug TB006 can safely improve motor function in people with early-stage Parkinson's disease. About 62 participants will receive either TB006 or a placebo by IV infusion. The study is double-blind, meaning neither patients nor doctors know who…

This study is testing whether a 6-month program of online exercise classes, guided meditation, and nutrition advice can improve thinking, sleep, and overall health in people with Parkinson's disease. 60 participants aged 40 to 85 will take part, with some starting the program rig…

This study looks at whether adding resistance (strength) exercises to standard aerobic and balance training can improve quality of life, daily activities, thinking skills, and muscle health in people with early-stage Parkinson's disease. About 34 adults aged 40-70 with mild to mo…

This study looks at how thinking, memory, and movement change in older adults with conditions like dementia or Parkinson's disease. Researchers will use tests, brain scans, and lab samples to find clues for earlier diagnosis and better care. About 260 people, including healthy vo…